We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+7.4%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$362M
AUM Growth
+$130M
Cap. Flow
+$60.7M
Cap. Flow %
16.76%
Top 10 Hldgs %
69.22%
Holding
71
New
28
Increased
4
Reduced
7
Closed
16

Sector Composition

Rank Sector Weight
1 Healthcare 14.5%
2 Technology 3.17%
3 Industrials 2.43%
4 Consumer Discretionary 1.37%
5 Energy 1.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENLT icon
26
Enlight Renewable Energy
ENLT
$11.4B
$1.59M 0.44%
+94,183
New +$1.59M
APLS
27
DELISTED
Apellis Pharmaceuticals
APLS
$1.4M 0.39%
+21,259
New +$1.23M
ETNB
28
DELISTED
89bio
ETNB
$1.14M 0.32%
+75,000
New +$978K
WHD icon
29
Cactus
WHD
$5.52B
$1.13M 0.31%
+27,500
New +$1.33M
AWK icon
30
American Water Works
AWK
$26.6B
$1.1M 0.3%
+7,500
New +$1.11M
RVMD icon
31
Revolution Medicines
RVMD
$44.6B
$866K 0.24%
+40,000
New +$985K
PCG icon
32
PG&E
PCG
$38.3B
$809K 0.22%
+50,000
New +$790K
CWAN
33
DELISTED
Clearwater Analytics
CWAN
$718K 0.2%
+45,000
New +$787K
LOCO icon
34
El Pollo Loco
LOCO
$465M
$713K 0.2%
+74,400
New +$847K
CDTX
35
DELISTED
Cidara Therapeutics
CDTX
$469K 0.13%
+18,455
New +$524K
GSBD icon
36
Goldman Sachs BDC
GSBD
$1.1B
$438K 0.12%
+32,100
New +$479K
RAIN
37
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$272K 0.08%
31,159
-283,012
-90% -$2.62M
AVTX icon
38
Avalo Therapeutics
AVTX
$1.02B
$105K 0.03%
+250
New +$197K
SRZNW icon
39
Surrozen Inc Warrant
SRZNW
$8.86K
$12K ﹤0.01%
+120,382
New +$9.75K
ACDC icon
40
ProFrac Holding
ACDC
$827M
-25,000
Closed -$630K
ASLE icon
41
AerSale
ASLE
$270M
-42,344
Closed -$687K
ASPN icon
42
Aspen Aerogels
ASPN
$549M
-505,000
Closed -$5.95M
AURA icon
43
Aura Biosciences
AURA
$817M
-131,640
Closed -$1.38M
COR icon
44
Cencora
COR
$61.6B
-45,000
Closed -$7.46M
CRGY icon
45
Crescent Energy
CRGY
$3.95B
-175,000
Closed -$2.1M
DYN icon
46
Dyne Therapeutics
DYN
$4.89B
-123,719
Closed -$1.43M
GTLS.PRB
47
DELISTED
Chart Industries 6.75% Series B Preferred Stock
GTLS.PRB
-150,000
Closed -$7.6M
INDI icon
48
indie Semiconductor
INDI
$811M
-350,000
Closed -$2.04M
KPTI icon
49
Karyopharm Therapeutics
KPTI
$47.6M
-32,113
Closed -$1.64M
NFE icon
50
New Fortress Energy
NFE
$100M
-87,700
Closed -$3.72M

Similar funds

Monashee Investment Management's Q1 2023 Portfolio in Review

As of Q1 2023, Monashee Investment Management held 71 positions worth $362M, up 56% from $232M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Monashee Investment Management deployed $60.7M of net new capital in Q1 2023, opening 28 new positions and adding to 4 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 95,000 shares worth $16.9M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Chart Industries, an estimated $8.18M trimmed.

  • Monashee Investment Management's largest Q1 2023 buy was iShares Russell 2000 ETF: 95,000 shares worth $16.9M.
  • Monashee Investment Management added most to Vanguard Morningstar Total Stock Market ETF in Q1 2023, an estimated $91.1M increase.
  • Monashee Investment Management's biggest Q1 2023 reduction was Chart Industries, cutting an estimated $8.18M.
  • Monashee Investment Management fully exited Constellation Brands in Q1 2023, selling an estimated $9.27M.
  • Monashee Investment Management's ten largest holdings make up 69% of its $362M portfolio in Q1 2023.
  • Monashee Investment Management opened 28 new positions and closed 16 in Q1 2023.
  • Monashee Investment Management's portfolio value rose 56% quarter-over-quarter to $362M.

Based on Monashee Investment Management's 13F filing for Q1 2023, filed 5 May 2023.